ClinicalTrials.Veeva

Menu

Effects of Gastrostomy on Amyotrophic Lateral Sclerosis

U

University Hospital, Clermont-Ferrand

Status

Completed

Conditions

Amyotrophic Lateral Sclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT00337402
CHU63-0001

Details and patient eligibility

About

Results about effects of symptomatic treatment on QoL appears conflicting in ALS patients. Moreover no clear effects of gastrotomy have be shown on survival. Prospective study on effect of tube feeding, QoL and survival is performed in 17 teaching hospitals in France (observational study)

Full description

Following data have been recorded each three months: QoL (MOS-SF 36 and ALSAQ), bodily mass index, testing and ALS-FRS scale, functional respiratory measures, impedance analysis, and the time for tube feeding procedure, the conditions of the acceptance and side-effects of gastrotomy

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients > 18 years-old
  • ALS certain or probable
  • vital capacity (respiratory) > 70 %
  • under riluzole

Exclusion criteria

  • ALS in family
  • other conditions affected survival and QoL
  • cognitive impairment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems